Selected article for: "access care and actual purpose"

Author: Dos Santos, Tiago Jeronimo; Rodrigues, Ticiana Costa; Puñales, Marcia; Arrais, Ricardo Fernando; Kopacek, Cristiane
Title: Newest Diabetes-Related Technologies for Pediatric Type 1 Diabetes and Its Impact on Routine Care: a Narrative Synthesis of the Literature
  • Cord-id: e03ewrx8
  • Document date: 2021_8_20
  • ID: e03ewrx8
    Snippet: PURPOSE OF REVIEW: This review aims to address the actual state of the most advanced diabetes devices, as follows: continuous subcutaneous insulin infusions (CSII), continuous glucose monitoring systems (CGM), hybrid-closed loop (HCL) systems, and “Do-it-yourself” Artificial Pancreas Systems (DIYAPS) in children, adolescents, and young adults. This review has also the objective to assess the use of telemedicine for diabetes care across three different areas: education, social media, and dail
    Document: PURPOSE OF REVIEW: This review aims to address the actual state of the most advanced diabetes devices, as follows: continuous subcutaneous insulin infusions (CSII), continuous glucose monitoring systems (CGM), hybrid-closed loop (HCL) systems, and “Do-it-yourself” Artificial Pancreas Systems (DIYAPS) in children, adolescents, and young adults. This review has also the objective to assess the use of telemedicine for diabetes care across three different areas: education, social media, and daily care. RECENT FINDINGS: Recent advances in diabetes technology after integration of CSII with CGM have increased the popularity of this treatment modality in pediatric age and shifted the standard diabetes management in many countries. We found an impressive transition from the use of CSII and/or CGM only to integrative devices with automated delivery systems. Although much has changed over the past 5 years, including a pandemic period that precipitated a broader use of telemedicine in diabetes care, some advances in technology may still be an additional burden of care for providers, patients, and caregivers. The extent of a higher rate of “auto-mode” use in diabetes devices while using the HCL/DIYAPS is essential to reduce the burden of diabetes treatment. SUMMARY: More studies including higher-risk populations are needed, and efforts should be taken to ensure proper access to cost-effective advanced technology on diabetes care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40124-021-00248-7.

    Search related documents:
    Co phrase search for related documents
    • abstract title and adolescent child: 1
    • abstract title eligibility screen and adolescent child: 1
    • abstract title study and additional reference: 1
    • abstract title study and adolescent child: 1
    • abstract title study eligibility and adolescent child: 1
    • additional reference and adolescent child: 1